What’s New with PARP Inhibitors and Ovarian Cancer?

Advocating for Better Outcomes: Ovarian Cancer and You

PARP Inhibitors: 2023 Updates

The Groundbreaking Cancer Expert: (New Research) "This Common Food Is Making Cancer Worse!"

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023

The Promise of Pathbreaking Advances in Ovarian Cancer with Nanomedicine

PARP Inhibitors in GYN Cancers | 2022 Evolution Conference

Research Update: ROCkeTS – Early Stage Detection From Symptom-Triggered Testing

Intermediate Risk Prostate Cancer

What's New in Ovarian Cancer Research: 2023 Updates

Research Update: Using Shopping Data to Improve the Diagnosis of Ovarian Cancer

Organ Procurement in the U.S: Navigating Challenges & Shaping the Future

Connecting for Better Health Meeting: 11/14

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches

Vaccines for Older Canadians: An Update on What Everyone Needs to Know to Enable Healthy Ageing

Conversations on Cancer - Pediatric Cancers: Navigating the Challenges Together

Primary Peritoneal Cancer 101

Real-Time PCR in Action

Mechanisms of PARP Inhibition: A Mode of Targeted Cancer Treatment

The ABCs of ADCs: Ovarian Cancer and Antibody Drug Conjugates

All about treatment for recurrent ovarian cancer